News
20h
GlobalData on MSNFDA awards breakthrough therapy status to BMS and SystImmune’s NSCLC drug
NSCLC represents 80% of lung cancer cases and is the leading cause of cancer-related mortality globally. This designation is ...
Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking ...
China NMPA grants breakthrough therapy designation to Antengene’s ATG-022 to treat gastric/gastroesophageal junction adenocarcinoma: Shanghai Wednesday, August 20, 2025, 16:00 H ...
22h
Money Talks News on MSNTrump Administration Targets 12-Month Timeline for Psychedelic Drug Approvals
Trump administration accelerates psychedelic therapy timeline while Texas invests $50 million in breakthrough addiction ...
15hon MSN
World's first spinal cord transplant to take place in Israel, could allow patients to walk again
Tel Aviv University announced on Wednesday that the surgery will take place in Israel, marking a historic milestone in ...
Professor Peter Johnson, NHS England’s National Clinical Director for Cancer, said: “This is one of the most hopeful advances in decades for people with bladder cancer who will now be offered a ...
17h
IFLScience on MSNMerry Mice: Human Brain Cells Transplanted Into Mice Reduce Anxiety And Depression
Human stem cells developed into dopaminergic neurons have been transplanted into mice, resulting in reduced anxiety and ...
FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization ...
With federal funding, UCSF researchers develop technology to deliver electrical pulses based on patients’ own brain waves.
The Food and Drug Administration has granted Fast Track designation to CELZ-201-DDT for the treatment of degenerative disc disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results